Loading insider details...
Beta
Latest Form 4 (Sep 10, 2026): Grant/Award of 48,445 KRSA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 10, 2026 | Korsana Biosciences, Inc. (KRSA) | Grant/Award | 48,445 | n/a |
| Sep 3, 2026 | Apogee Therapeutics, Inc. (APGE) | Disposition to Issuer | 340,855 | n/a |
| Aug 11, 2026 | Apogee Therapeutics, Inc. (APGE) | Exercise/Conversion | 31,838 | $541.2K |
| Jul 20, 2026 | CRESCENT BIOPHARMA, INC. (CBIO) | Purchase | 853,450 | $12.38M |
| Jul 2, 2026 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/Award | 32,341 | n/a |
| Jul 2, 2026 | Oruka Therapeutics, Inc. (ORKA) | Conversion | 3,553,410 | n/a |
| Jun 24, 2026 | Spyre Therapeutics, Inc. (SYRE) | Conversion | 666,680 | n/a |
| Jun 12, 2026 | Apogee Therapeutics, Inc. (APGE) | Grant/Award | 7,657 | n/a |
| Jun 11, 2026 | Jade Biosciences, Inc. (JBIO) | Grant/Award | 34,843 | n/a |
| Jun 3, 2026 | CRESCENT BIOPHARMA, INC. (CBIO) | Grant/Award | 11,050 | n/a |